Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB13267ApprovedSmall molecule
Ritiometan is a nasal spray which is marketed by the name Nécyrane in France. It is indicated for use in viral rhinitis/ the common cold.
- Formula / weight
- C7H10O6S3 · 286.33 g/mol (avg)
Resolves to
Clinical / RWD
Structure
InChIKey
ZBNBQISDCFIEQC-UHFFFAOYSA-NSMILESOC(=O)CSC(SCC(O)=O)SCC(O)=OWhat you can answer from here — as of February 21, 2021
Which companies are running trials of Ritiometan, in which indications and phases, and which of those programs are still active?